Novistra Capital
transaction-bg-2560x945

November 2016

United States & India

Novistra Capital advises Global Revenue Cycle Partners on its majority exit to ACN Technologies

Client

Global Revenue Cycle Partners

Deal Type

Sell-Side M&A

Deal Team

Ripun-1-120x120

Ripun Jai Mehta

Managing Partner

Client Description

“Global Revenue Cycle Partners (GRCP) is a healthcare-focused revenue cycle management (RCM) company with operations in Pittsburgh, PA and Bangalore, India. GRCP provides end-to-end medical billing, coding, and collections services to U.S. healthcare providers, and has established itself as a fast-growing player in the mid-market RCM space.

ACN Technologies, a part of the ACN Infotech Group, is a global BPO and technology company with offices in Los Angeles, New Jersey, Germany, and India. ACN delivers outsourcing services to clients in healthcare, insurance, entertainment, and industrial sectors. The firm also offers an enterprise-grade document management platform used by clients worldwide.”

Approach

“GRCP engaged Novistra Capital to advise on a strategic majority exit. The objective was to find a partner with complementary capabilities, global reach, and the ability to help scale the platform across the U.S. and European markets. Novistra led a focused M&A process—positioning GRCP’s U.S.-India model and domain expertise as highly synergistic with ACN’s operational strengths and client footprint.

Novistra structured a transaction that enabled the founders to realise value while continuing to drive growth through a larger platform.”

Outcome

GRCP sold a majority stake to ACN Technologies, forming a powerful combination with expanded delivery capabilities, deeper client access, and a broader product suite. The partnership positions GRCP to accelerate its penetration of the U.S. healthcare market and scale globally through ACN’s established infrastructure.

Press Releases

techservices-2560x392

December, 2019

Novistra Capital advises Global Revenue Cycle Partners for a majority exit to ACN Technologies

Read more

Related Transactions

Acquired

Buy-side advisor to CX1 Capital

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Novistra Capital advises CX1 Capital on its acquisition of SatCom Marketing

Outcome: Exclusive buy-side advisor to CX1 Capital, a tech-driven investment firm that focuses on lower middle market buy & build strategies using AI.

Acquired by

A portfolio company of

Sell-side advisor to CTI Data

Novistra Capital advises CTI Data on its sale to OneSix

Exclusive sell-side advisor to CTI Data, a leading data consultancy, on its sale to OneSix,...

Outcome: Acquisition creates a differentiated Snowflake data and scaled AI platform.

Acquired by

A portfolio company of

Sell-side advisor to Yexle

Novistra Capital advises Yexle on its sale to IGT Solutions, an EQT portfolio company

Exclusive sell-side advisor to Yexle, a leading Appian solutions and services partner.

Outcome: Added cutting-edge Appian delivery capabilities to IGT’s digital transformation practice.

Acquired by

A portfolio company of

Sell-side advisor to NetServ

Novistra Capital advised NetServ on its acquisition by Accion Labs, a portfolio company of TA Associates

Served as exclusive sell-side advisor to NetServ on its acquisition by Accion Labs, a global...

Outcome: Strengthened engineering capabilities and delivery presence across key markets

Acquired by

A portfolio company of

Sell-side advisor to SG Analytics

Novistra Capital advised SG Analytics on its acquisition by Straive, a portfolio company of EQT

SG Analytics engaged Novistra Capital as its exclusive sell-side advisor on its acquisition by Straive,...

Outcome: Created one of the leading integrated data and analytics platforms

Acquired by

A portfolio company of

Sell-side advisor to Cloud Development Resources

Novistra Capital advised Cloud Development Resources on its majority sale to emids

CDR engaged Novistra Capital to lead a targeted process culminating in its sale to emids,...

Outcome: Established the healthcare industry’s first dedicated low-code practice

Majority investment in

Buy-side advisor to Excelra

Novistra Capital advised Excelra on its majority investment in Anilitiks

Served as exclusive buy-side advisor to Excelra on its acquisition of Anilitiks, strengthening Excelra’s HEOR...

Outcome: Expanded Excelra’s data-driven Life Sciences solutions portfolio

Merged with

Buy-side advisor to ACN Healthcare

Novistra Capital advised ACN Healthcare on its merger with Rapid Care’s RCM business

Advised ACN Healthcare on its merger with the RCM business of Rapid Care Group, creating...

Outcome: Merger created a scaled, integrated healthcare RCM platform

License agreement with

Financial advisor to IDD Bio Tech

Novistra Capital advised IDD Biotech on its license agreement with Enzene Biosciences, a subsidiary of Alkem Labs

IDD Biotech appointed Novistra Capital to structure and negotiate a licensing deal for its CD19...

Outcome: Exclusive licensing agreement with Enzene Biosciences completed

Acquired by

Sell-side advisor to Pacific BPO

Novistra Capital advised Pacific BPO on its sale to Access Healthcare

Exclusive advisor to Pacific BPO on its sale to Access Healthcare, creating one of the...

Outcome: Completed sale of Pacific BPO to Access Healthcare

Rectangle-426-1-scaled-2560x718

Clarity starts with
a conversation